Thomas Cahill

Insider Reports History

Entity
Individual
Location
Prime Medicine, Inc., 21 Erie St., Cambridge, MA
Signature
/s/ Karen Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Cahill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Director Stock Option (right to buy) 45K Jun 12, 2024 Direct

Insider Reports Filed by Thomas Cahill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
PRME Prime Medicine, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
PRME Prime Medicine, Inc. Oct 24, 2022 4 $6.8M 4 Oct 26, 2022 Director
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 Director